On the Possibility of Using Succinate in Hypoxia Developing in COVID-19
Aim. To provide a rationale for the feasibility of using the succinate-containing drugs to treat hypoxia associated with COVID-19 based on the analysis of experimental and clinical studies.Materials and methods. 84 Russian and international literature sources concerning the pathogenesis of COVID-19...
Main Authors: | Yu. P. Orlov, N. V. Govorova, O. V. Korpacheva, V. V. Afanasyev, I. A. Khilenko |
---|---|
Format: | Article |
Language: | English |
Published: |
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia
2021-07-01
|
Series: | Общая реаниматология |
Subjects: | |
Online Access: | https://www.reanimatology.com/rmt/article/view/2084 |
Similar Items
-
Pathophysiological Aspects of Hyperoxia in Anesthesiologist-Reanimatologist's Practice
by: Vladimir T. Dolgikh, et al.
Published: (2017-06-01) -
CHANGES IN THE GLUTATHIONE SYSTEM IN P19 EMBRYONAL CARCINOMA CELLS UNDER HYPOXIC CONDITIONS
by: D. S. Orlov, et al.
Published: (2015-08-01) -
EFFECT OF N-ACETYLCYSTEINE ON APOPTOSIS OF P19 CANCER CELLS DURING HYPOXIA
by: O. L. Nosareva, et al.
Published: (2020-07-01) -
Role of Succinates in Critical Conditions
by: Yu. P. Orlov, et al.
Published: (2014-12-01) -
Molecular mechanisms of the effects of N-ethylmaleimide and 1,4-dithioerythritol on regulation of apoptosis in P19 cells under hypoxia
by: O. L. Nosareva, et al.
Published: (2020-07-01)